Synaptogenix Valuation
| SNPX Stock | USD 4.76 0.24 5.31% |
At this time, the company appears to be overvalued. Synaptogenix has a current Real Value of $4.31 per share. The regular price of the company is $4.76. Our model measures the value of Synaptogenix from inspecting the company fundamentals such as Return On Equity of -0.2, shares outstanding of 1.09 M, and Shares Owned By Institutions of 3.92 % as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Synaptogenix's price fluctuation is very risky at this time. Calculation of the real value of Synaptogenix is based on 3 months time horizon. Increasing Synaptogenix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Synaptogenix is useful when determining the fair value of the Synaptogenix stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Synaptogenix. Since Synaptogenix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Synaptogenix Stock. However, Synaptogenix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.76 | Real 4.31 | Hype 4.76 | Naive 4.71 |
The real value of Synaptogenix Stock, also known as its intrinsic value, is the underlying worth of Synaptogenix Company, which is reflected in its stock price. It is based on Synaptogenix's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Synaptogenix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Synaptogenix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Synaptogenix helps investors to forecast how Synaptogenix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Synaptogenix more accurately as focusing exclusively on Synaptogenix's fundamentals will not take into account other important factors: Synaptogenix Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Synaptogenix's current stock value. Our valuation model uses many indicators to compare Synaptogenix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Synaptogenix competition to find correlations between indicators driving Synaptogenix's intrinsic value. More Info.Synaptogenix is rated below average in price to book category among related companies. It is rated third in beta category among related companies totaling about 7.21 of Beta per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Synaptogenix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Synaptogenix's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Synaptogenix's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Synaptogenix's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Synaptogenix and how it compares across the competition.
About Synaptogenix Valuation
The stock valuation mechanism determines the current worth of Synaptogenix on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Synaptogenix. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Synaptogenix based exclusively on its fundamental and basic technical indicators. By analyzing Synaptogenix's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Synaptogenix's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Synaptogenix. We calculate exposure to Synaptogenix's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Synaptogenix's related companies.Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company was incorporated in 2012 and is headquartered in New York, New York. Synaptogenix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
8 Steps to conduct Synaptogenix's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Synaptogenix's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Synaptogenix's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Synaptogenix's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Synaptogenix's revenue streams: Identify Synaptogenix's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Synaptogenix's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Synaptogenix's growth potential: Evaluate Synaptogenix's management, business model, and growth potential.
- Determine Synaptogenix's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Synaptogenix's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Synaptogenix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Synaptogenix does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 466.1 K |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synaptogenix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Synaptogenix Stock analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Synaptogenix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synaptogenix. If investors know Synaptogenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synaptogenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Synaptogenix is measured differently than its book value, which is the value of Synaptogenix that is recorded on the company's balance sheet. Investors also form their own opinion of Synaptogenix's value that differs from its market value or its book value, called intrinsic value, which is Synaptogenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synaptogenix's market value can be influenced by many factors that don't directly affect Synaptogenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synaptogenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Synaptogenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synaptogenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.